SCHEMBL9344792

SCHEMBL9344792

O=P(O)(O)Cc1cc(CBr)cc(-c2ccc(Cl)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN2D O15399 1/20 0.46
▸ GRIN3B O60391 1/20 0.46
▸ GRIN1 Q05586 1/20 0.46
▸ GRIN2A Q12879 1/20 0.46
▸ GRIN2B Q13224 1/20 0.46
▸ GRIN2C Q14957 1/20 0.46
▸ GRIN3A Q8TCU5 1/20 0.46
▸ PGK1 P00558 3/20 0.43
▸ PGK2 P07205 3/20 0.43
▸ MEN1 O00255 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ PTPN5 P54829 2/20 0.39
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ MMP2 P08253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22973707 0.81 PGK1 (0.61) PGK1PGK2PTPRB
SCHEMBL9344811 0.76 MEN1 (0.69) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL9345161 0.76 MEN1 (0.56) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL916912 0.73 PGK1 (0.59) PGK1PGK2MEN1KMT2AMMP2
SCHEMBL9343960 0.73 MEN1 (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Phosphoric Acid SCHEMBL11140164 0.72 PGK1 (0.57) PGK1PGK2MEN1KMT2AMMP2
SCHEMBL4848690 0.72 PGK1 (0.57) PGK1PGK2MEN1KMT2AMMP2
SCHEMBL3361713 0.71 PGK1 (0.56) PGK1PGK2PTPRB
SCHEMBL8824567 0.71 PGK1 (0.76) PGK1PGK2PTPRB
SCHEMBL8992166 0.70 ACP3 (0.48) PGK1PGK2MEN1ALOX15CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5321016-A Epliepsy, central nervous system disorders SANDOZ PHARMACEUTICALS CORP. (US) 1994-06-14 — — US disclosed
US-5162311-A Treating epilepsy, psychiatric disorders SANDOZ PHARMACEUTICALS CORP. (US) 1992-11-10 — — US disclosed
Send feedback